Interestingly, expression levels of identified alternatively spliced exons are decreased in the AD and the minor allele of one SNP in RELN potentially affecting exon skipping negatively correlate with a global cortical amyloid-β burden. This evidence concerns the gene RELN and Alzheimer disease.